Become a Sponsor/Exhibitor :

Become a Sponsor

Conference Organizing Committee :

View Committee

Conference Program :

Brochure Download


  • Clinical Trials on Different Diseases
  • Design of Clinical Studies and Trials
  • Site Management Innovation
  • Bioethics and Regulatory Compliance
  • Future of Clinical Trials
Read More


Abstract Submission

Early Bird Registration

Scientific Committee

Click on the image to view biography

Dr. Qais Abu Ali

Independent Consultant, USA

Abu Ali, an American-board certified geneticist-physician based in USA, is a consultant and advisory board member for various global pharmaceuticals, genomics and biotechnology companies. He specializes in clinical drug development and safety, clinical trial design and conduct, genomics and molecular diagnostics. Additionally, he sees patients with rare genetic and inherited diseases in his international telegenetics clinic. He held multiple advancing leadership and executive roles in clinical practice, molecular diagnostic labs, and pharmaceuticals. He led various rare-disease drug development programs yielding successful approvals by regulatory authorities in the US, EU and other regions, and continues to present his work in scientific conferences and journals.

Dr. Eduardo Motti

Trials & Training Consult, Brazil

Eduardo Motti graduated in Medicine and completed residency and a mastership in infectious disease at University of Sao Paulo, Brazil. In 1984, he joined the pharmaceutical industry, working for Merck Sharp & Dohme until 2001, when he started the activities of Eurotrials in Brazil (a CRO originally from Portugal). Later, he moved back to Pharma and joined Schering AG, now Bayer, then Pfizer, where he was the Regional Director of Clinical Operations for Latin America. In 2012 he started Trials & Training, a consulting company and became a certified Executive Coach. Overall Dr. Motti has worked in more than 500 clinical research projects, and provided technical training, coaching and mentoring for hundreds of health care professionals.

Gabe Goldfeder

Director of Clinical Operations, Pintails Solutions serving the Global Alzheimer’s Platform Foundation (GAP), USA

Gabe has been the Director of Clinical Operations for Pintails Solutions serving the Global Alzheimer’s Platform Foundation (GAP) since April 2015. Gabe has extensive experience in managing clinical research sites. At GAP, Gabe is enabling the development of a first in class network of AD research sites, referred to as GAP-Net. Most recently he was running G2 CRC LLC, a consulting company specializing in bringing clinical trials to research naïve sites. In his over 15 year career, Gabe has held several site roles including site director, C.R.C. and cognitive rater. He has worked in both commercial and academic environments including the Nathan Kline Institute, Comprehensive Neuroscience and Ecast. He holds a Master’s degree in Psychology from New York University. Gabe is A.C.R.P. certified and has contributed to investigator-initiated proposals and published abstracts including one for the American Psychiatric Association in 2007.

James Mash


James Mash founded Patient Focused Solutions, Inc. in 2017. Mr. Mash has demonstrated success in setting up clinical research centers in the USA, Europe, Mexico and Southeast Asia. Those organizations have successfully conducted many trials for the global pharmaceutical and biotech industry. Mash has been in the pharma/biotech support industry for more than 3 decades.

Dr. Charles Schmidt

VP of Clinical Development & Regulatory Affairs, Farmacon Global, Brazil

Charles Schmidt is a trained Pediatrician with Master and Doctorate degree in Pediatric Infectious Disease. He has been practicing and teaching while working in the biopharma for the past 28 years. He had developed and managed successfully big and medium size CROs in Latin America and at their global level for more than 15 years. His experience also includes leadership roles in Medical Affairs, Pharmacovigilance , and Medical Monitoring  in Pharmaceutical companies. Charles has an extensive background in clinical development in different therapeutic efforts in LatAm and globally. He is an attending physician in coordinating the post-graduation program in clinical research at Santa Casa Medical School in Sao Paulo-Brazil since 2007. Also, he is the medical manager of the central institute of clinical research at Hospital de Clinicas-FFM, USP-Sao Paulo. Charles was the founder and ex-president of the Brazilian Association of CROs (ABRACRO) and vice-president (2018-2022) of the Brazilian Association of Pharmaceutical Physicians.

Dr. Narayanachar Murali

MD, FACP, FACG, DNBPAS, Gastroenterology Associates of Orangeburg, USA

Murali is a Consultant Gastroenterologist who works both in his office based surgery and with the Regional Medical Center in Orangeburg SC, USA. He has been in practice for 26 years and conducts numerous clinical trials -Phase II-III in his office practice, lately with a focus on inflammatory bowel diseases. He has extensive experience in the clinical trials operations and has studied the evolution of the complexity of trials over the decades. He runs a successful private practice with outstanding patient satisfaction. He has a wide variety of interests including diagnostic and therapeutic endoscopy, teaching, clinical trials, computing and software design and execution. He uses continuous quality improvement techniques in his clinical practice. He is assisted in the conduct of trials by Anuradha Murali , PhD, MSCR, who works as the director of Clinical trials and his sub investigator.

Dr. Eric Vang

Sr. Director, Clinical Research and Medical Affairs for Cardiac Surgery, Medtronic, USA

Eric Vang, PhD, MPH is a Sr. Director, Clinical Research and Medical Affairs for Cardiac Surgery for Medtronic. He has a background in Epidemiology with over 20 years of Clinical Research experience in MedTech/Biotechnology Sponsors. For the past 15 years, Eric’s focus has been in Structural Heart and Cardiac Surgery leading global teams, programs and developing clinical evidence demonstrating safety and effectiveness in new therapies in early feasibility studies to global, multi-center, randomized controlled trials. Eric also a member of the international standards (ISO) for cardiac implants and extracorporeal systems – cardiac valve devices and prosthesis.

About Conference

It is with an immense pleasure and a great honor, we would like to welcome you all to participate at our International conference on Advanced Clinical Trials and Clinical Research conference to be held during March 28-29, 2022 in Barcelona, Spain.

The conference is hosted by Linkin Science. These conferences are well crafted and designed by a team of skilled experts. Our conferences are vast expanded into Medical, life sciences, health care, Engineering and other social sciences. Each conference, summit or executive briefing is tailored to the sector, topic and audience need. Our event structure varies depending on issue and market requirements featuring Keynote presentations, Oral talks, Poster presentations, Young research forum, Exhibitions, roundtables and variable formats. Our mission is to bring the researchers on a common platform and provide opportunity for them to interact. This scientific networking helps for the betterment of science by exchanging the ideas in a broader way. Magnifying Scientific Knowledge by Sharing the research and ideas. We believe in accelerating the possibilities of novel discoveries and enhancement in scientific research, by connecting scientific community for knowledge sharing. Join us to redefine and explore new research, to provide a credible source to barter ideas for scientific studies besides transforming the true outcomes of a distinct scientific discovery and grab the attention for rare emerging technologies.

Importance and Scope:

Clinical Trials and Clinical Research 2022 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about clinical research and its advances. This is your best opportunity to reach the largest assemblage of participants from Clinical Trials and Clinical Research community that is from academia, clinical research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical companies, biomedical and medical device industries.

Clinical trials are a key research tool for advancing medical knowledge and patient care. Clinical research is done only if doctors do not know whether a new approach works well in people and is safe, and which treatments or strategies work best for certain illnesses or groups of people. Clinical trials are important for discovering new treatments for diseases, as well as new ways to detect, diagnose, and reduce the chance of developing the disease. Clinical trials can show researchers what does and doesn’t work in humans that cannot be learned in the laboratory or in animals. Clinical trials also help doctors decide if the side effects of a new treatment are acceptable when weighed against the potential benefits. Researchers don’t know what the results of clinical trials will be. (If they did, they wouldn’t have to do the trials!) This uncertainty can make it hard for a patient to decide to participate in a clinical trial. While in rare cases, patient volunteers have been hurt by the treatment or procedure on a clinical trial, millions of people have been helped because other people before them chose to participate in a trial that resulted in a new, more effective treatment.


Benefits of attending the conference:

This conference offers a wonderful opportunity to meet and enhance new contacts in the field of Clinical Research by providing mutual collaboration and break-out rooms with tea, Coffee, snacks and lunch for delegates between sessions with invaluable networking time for you. It allows delegates to have issues addressed on Clinical Trials and Clinical Research global experts who are up to date with the latest developments in this particular field and provide information on new advancements and other technologies. This International conference features world renowned keynote speakers, plenary speeches, young research forum, poster presentations, technical workshops and career guidance sessions.

Target Audience:

  • Clinical Development Directors
  • Clinical Project Managers
  • Head Clinical Operations
  • Clinical Trails Outsourcing
  • Clinical Country Leads
  • Medical Affairs Directors
  • Head Risk Based Monitoring
  • Head Clinical Trials Managements
  • Clinical Oversight
  • Clinical R&D
  • Budgeting and Outsourcing Directors
  • Clinical Informatics Directors
  • Site Manager Director
  • Data Management Heads
  • Clinical Statistics Directors
  • Head Early Clinical Development
  • Head Patient Excellence
  • Director Medical and Regulatory Affairs
  • Director Feasibility
  • Innovation Head
  • Clinical Site Managers

Scientific Sessions

Clinical Trials on Different Diseases:

Clinical Trials for various infections and clutters are led for assessing at least one medication (for instance, drugs, restorative gadgets, and ways to deal with surgery or radiation treatment) for treating a malady, disorder, or condition furthermore discovering approaches to keep the underlying advancement or repeat of an ailment or condition. These can incorporate meds, immunizations, or way of life changes, among different methodologies. A diabetes prevention clinical research is testing whether a successful, but expensive, hospital-based strategy of identifying people with pre-diabetes and helping them lose weight can be adapted to be delivered at the community level, using peer-led interventions.


Design of Clinical Studies and Trials:

Clinical review configuration is the definition of trials and tests, and in addition observational reviews in restorative, clinical and different sorts of research including people. Clinical research are normally led in four stages, every stage is considered as particular trial and, after finish of a stage, examiners are required to present their information for endorsement from the FDA before proceeding to the following stage. By partaking in clinical trials, members cannot just assume a more dynamic part in their own particular social insurance, yet they can likewise get to new medications and help other people by adding to therapeutic research. Sorts of Study Designs Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Comparative Study, Case-control Study, Cross-sectional review, Case Reports and Series, Animal Research Studies, Test-tube Lab Research


Site Management Innovation:

Includes setting desires, being sorted out and building up measurements to track execution, and building and fortifying associations with following destinations like Identify instruments for site distinguishing proof, assessment and choice, Discuss techniques for enhancing the site/support/CRO relationship, Discuss best practices for guaranteeing general investigation achievement The site is typically a doctor's facility or a comparable human services foundation that has satisfactory framework and staff to meet the necessities of the clinical trial convention. A  related administrations to an agreement explore association (CRO), a pharmaceutical organization, a biotechnology organization, a restorative gadget organization or a clinical site. The site is normally a doctor's facility or a comparable service foundation that has sufficient framework and staff to meet the prerequisites of the clinical trial convention.


Bioethics and Regulatory Compliance:

Bioethics is the investigation of the commonly questionable moral issues rising up out of new circumstances and potential outcomes realized by advances in medication. It is additionally moral insight as it identifies with therapeutic approach, practice, and research. Bioethicists are worried with the moral inquiries that emerge in the connections among life sciences, biotechnology, prescription, clinical research, and reasoning and so forth. One of the principal ranges tended to by present day bioethicists was that of human experimentation. The National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research was at first settled in 1974 to recognize the fundamental moral rule that ought to underlie the lead of biomedical and behavioural research including human subjects. Clinical research morals are the arrangement of significant morals considered in the direct of a clinical trial in the field of clinical research. It acquires from the more extensive fields of research morals and restorative morals. Nature of clinical trials relies on upon information respectability and subject security. Globalization, outsourcing and expanding multifaceted nature of clinical trials have made the objective of accomplishing worldwide quality testing. The quality, as judged by administrative assessments of the examiner locales, supports/contract inquire about associations and Institutional Review Board, has been of worry to the US Food and Drug Administration, as there has been not really any adjustment in recurrence and nature of basic insufficiencies. Great Clinical Practice (GCP) is the general moral and logical quality standard for leading clinical trials. The GCP standard applies to all parts of the clinical trial.


Future of Clinical Trials:

Remote medical caretakers visit the subject at their homes to gather tests. What's more, the patient uses the portable wellbeing gadget to naturally transfer think about information specifically to the support's EDC database. Recent advances in clinical research have enabled to understand the molecular basis of disease. Equally important, a growing suite of biomarkers now provides predictive value for diagnosis and prevention/remission. Clinical research techniques are targeting new sources of information from patients, recognizing the uniqueness of individual subjects and producing massive quantities of data. Clinical research toolbox has grown so extensively that the research community is no longer limited.


Epidemiology and Public Health:

The feature of the study of disease transmission worried about distinguishing wellbeing related circumstances and end results. Investigative the study of disease transmission intends to research and study hazard and defender components of infections and recognize factors in an unhealthy populace that differs from a non-ailing populace. Where engaging the study of disease transmission depicts on account of infection inside a populace, it comprehends that comprehends the event of illness. The typical approach to pick up this learning is by aggregate correlations. Such an examination begins from at least one speculation about how the determinant may impact event of illness. Investigative the study of disease transmission decides the reason for an episode. Utilizing the case control strategy, the disease transmission specialist can look on the main considerations that may cause the illness


Innovations in Pre-clinical Research:

Pre-clinical research likewise named pre-clinical reviews and nonclinical studies is a phase of research that starts before clinical trials, and amid which imperative plausibility, iterative testing and medication security information is gathered. The principle objectives of clinical research reviews are to decide the sheltered measurements for First-in-man study and begin to survey item's security profile. Items may incorporate new or iterated or like-kind restorative gadgets, drugs, and so forth. This research increases knowledge about functional processes in living organisms and development. This Clinical research provides the building block upon which other types of biomedical research. Pre-clinical Research involves the evaluation of therapeutic intervention in humans and animals. Candidates for entry into clinical trials can then be selected based on their effectiveness and safety. All drugs require data from various toxicological preclinical studies to support their potential safety in humans before clinical trials before trail begin.


Clinical Data Management and Statistics:

The procedure of ID, examination and either acknowledgment or relief of instability in venture basic leadership Essentially, chance administration happens at whatever time a financial specialist or store chief clinical research investigates and endeavours to measure the potential for misfortunes in a speculation and afterward makes the suitable move given their speculation targets and hazard resistance. Insufficient hazard administration can bring about serious outcomes for organizations and in addition people. A practice utilized by various organizations to lessen costs by exchanging parts of work to outside providers instead of finishing it inside is called Outsourcing. It is a vital device for lessening cost and enhancing quality. Cancer research On the off chance that an association does one or all its work without anyone else, its work may influence its generation quality, so an study design association must understand some vital ranges, from which its cost is diminished and its items remain in high calibre..


Patient Recruiting & Retention:

Enlisting and selecting patients for clinical trials can frequently be a long and troublesome process. It's not shocking at that point, that finding the objective statistic, qualifying and selecting patients can expend significant time and cash. Hence, it is basic that the way toward enrolling is all around arranged and fits inside the convention spending plan and timetable. When patients are enlisted in an examination, it can be similarly as difficult to hold them. An assortment of startling variables can lead patients to pull back from the examination, bringing about insufficient information and conceivably, a costlier clinical trial. Before you set out on a patient enlistment crusade, it is vital to have an arrangement. Taking a gander at your accessible assets, doing your examination, and defining objectives can enable spare to time and cash over the long haul. The best and minimum costly patient to select into an examination originates from the site's own particular database or practice. These patients as of now have an association with the site, know about their examination, and have been most agreeable while taking an interest in investigate. Consequently, setting the site up for viable inside enlistment through enrolment arranging is imperative to the accomplishment of any investigation.


Covid-19 clinical trials:

The COVID-19 pandemic has disrupted clinical trials worldwide, with long-lasting effects on medical science. The COVID-19 pandemic has created massive disruptions to clinical trial research across the world. As in other aspects of life, the virus has severely affected the ability to conduct trials in safe and effective ways. This is especially true when considering that trials often deal with vulnerable populations who are most at risk from exposure to COVID-19. Thousands of trials have been suspended or stopped because of the difficulties in continuing under lockdown conditions, even as those restrictions have begun to ease in parts of the world.


Oncology Clinical Research:

Oncology is a branch of prescription that arrangements with tumours. A therapeutic expert who hones oncology is an oncologist. Integrative oncology deals with the brain, body, and soul. Modalities of development, touch, nourishment, and care are utilized inside routine disease care to address and enhance indications and personal satisfaction. That is the reason numerous experts, including medicinal specialists, have grasped the quickly extending field of integrative oncology, which melds the best of customary and option medications. Immuno-oncology treatments enact our invulnerable framework, making it ready to perceive growth cells and annihilate them. Since tumour cells are altogether different from ordinary cells in the body, the resistant framework assaults them when it can remember them. Neuro-oncology assesses and treats individuals with essential and optional tumours of the cerebrum, spinal line, and the layers encompassing the mind and spinal rope (meninges). Oncologic Emergencies, as the term infers, are difficulties coming about because of a growth itself, a paraneoplastic disorder, or from treatment of malignancy that require prompt consideration and inversion, if conceivable. Inpatient treatment is an absolute necessity, and frequently these conditions require intercession in an escalated mind setting.


Biomarkers in Clinical Trials:

Biomarkers are frequently being included in early-phase clinical trials. This article is meant to introduce clinical investigators to the fundamentals of choosing a biomarker test for use in an early phase trial. Steps to consider are briefly outlined including defining the role of the biomarker in the early phase trial; selecting a fit-for-purpose biomarker test and laboratory; describing the test procedures; carrying out analytical validation testing appropriate for the research objectives and the risk involved in the trial; implementing the test in the trial; and planning for the future.


Healthcare Outcomes and Pharmacoeconomics:

Pharmacoeconomics and health outcomes research are playing an increasingly important role in informing clinical development and market access decisions of new innovative medicines. Both disciplines are dealing with the evaluation of the costs and outcomes of healthcare interventions and can be considered as two branches of the same “value for money” tree. Pharmacoeconomics is the part of health economics that focuses on the economic evaluation of pharmaceuticals. Health outcomes research, and patient-reported outcomes (PRO) in particular, aim at understanding patient value in terms of impact of disease and its treatment on physical functioning and psychosocial wellbeing, known also as “health-related quality of life” (HRQL). PRO's are usually measured by self-reported questionnaires, thereby reflecting the patient's own viewpoint on the value of a new medicinal product. In many clinical development studies, HRQL is nowadays routinely measured to help establish the product's value for purposes of pricing and reimbursement.


HIV Clinical Trials:

Pretty much everything we know about how HIV treatment depends on research—and not just any research, but clinical trials involving people living with HIV. Today’s men, women and children living with HIV have yesterday’s clinical trial volunteers to thank for the highly effective, better tolerated and easier-to-take medications now available. Similarly, the future of our ability to respond to the needs of people living with HIV—whether its novel drugs for those starting therapy for the first time or in desperate need of new agents, new approaches to managing side effects or, best of all, a cure for the disease—depends greatly on people to continue enrolling in clinical trials today.


Paid Research Studies Market Analysis:

Clinical trials are the major breakthrough in the development of the drug. Such clinical trials are paid and conducted by government and private authorities. Such research studies are analyzed to determine the effect of the diseases or conditions.


Patient Stratification and Individualized Therapies:

It is well known that the drug discovery and development process is lengthy, expensive and prone to failure. This high failure rate is a significant factor in the pharmaceutical industry’s productivity problems, subsequent mergers and downsizing. Starting from the selection of a novel target in Discovery, through the multiple steps to regulatory approval, the overall probability of success is less than 1% (1). Given the time and resources needed to investigate a novel biological mechanism, ie one that has not been tested in humans before, success rates as low as these yield an unsustainable business model.


Randomized Controlled Trials:

A randomized controlled trial (or randomized control trial; is a type of scientific (often medical) experiment that aims to reduce certain sources of bias when testing the effectiveness of new treatments; this is accomplished by randomly allocating subjects to two or more groups, treating them differently, and then comparing them with respect to a measured response. One group—the experimental group—receives the intervention being assessed, while the other—usually called the control group—receives an alternative treatment, such as a placebo or no intervention. The groups are monitored under conditions of the trial design to determine the effectiveness of the experimental intervention, and efficacy is assessed in comparison to the control.


Latest technologies in Biomedical Research:

An incorporated approach utilizing compound, scientific and PC reenactments, in vitro tests, entire creature models, and human epidemiological examinations and clinical trials is right now the best way to deal with propel science, grow new items and medications, and treat, cure and anticipate sickness. Concoction, mechanical, numerical and PC recreations demonstrate most valuable in the preparatory phases of research where they can fortify thoughts regarding new research bearings. These are compelling examination models yet they can't supplant research center testing. PC reproductions are a successful research instrument since they increment speed and effectiveness of existing information. Human examinations include taking research center information on the security and adequacy of new immunizations or solutions and assessing them in precisely arranged clinical trials utilizing educated human volunteers. At the point when people are utilized as a part of biomedical research contemplates drugs are normally tried


Advancements in Psychology Research Methods:

Research psychology is directed in expansive accord with the measures of the logical strategy, including both subjective ethological and quantitative factual modalities to produce and assess informative speculations concerning mental marvels. Where look into morals and the condition of advancement in a given research space grants, examination might be sought after by exploratory conventions. Brain research has a tendency to be varied, drawing on logical learning from different fields to help clarify and comprehend mental marvels. Subjective mental research uses an expansive range of observational strategies; including activity inquire about, ethnography, exploratory measurements, organized meetings, and member perception, to empower the get-together of rich data unattainable by established experimentation. Research in humanistic brain research is all the more normally sought after by ethnographic, recorded, and historiographical methods. The testing of various parts of mental capacity is a huge zone of contemporary brain research. Psychometric and measurable techniques prevail, including different surely understood state administered tests and also those made specially appointed as the circumstance or analysis requires.


Stem Cell and Genetic Clinical Research:

Genetics is the fundamental basis of any organism so understanding of genetics will provide a powerful means to discover hereditary elements in disease etiology. In recent years, genetic studies have shifted from disorders caused by a single gene (e.g. Huntington’s disease) to common multi-factorial disorders (e.g. hypertension) that result from the interactions between inherited gene variants and environmental factors, including chemical, physical, biological, social, infectious, behavioural or nutritional factors. Stem cell are undifferentiated organic cells that can separate into particular cells and can isolate (through mitosis) to deliver more foundational microorganisms. They are found in multicellular life forms. In warm blooded creatures, there are two expansive sorts of foundational microorganisms: embryonic undifferentiated organisms, which are confined from the inward cell mass of blastocysts, and grown-up immature microorganisms, which are found in different tissues. In grown-up life forms, undifferentiated organisms and forebear cells go about as a repair framework for the body, renewing grown-up tissues


Market Analysis

The worldwide clinical trials advertise estimate was esteemed at USD 40.0 billion of every 2016 and is relied upon to develop at a CAGR of 5.7% over the gauge time frame. Key drivers affecting the market development are globalization of clinical trials, improvement of new medications, for example, customized prescription, expanding advancement in innovation, and boosting interest for CROs to lead clinical trials. CROs enhanced mastery when contrasted with pharma organizations concerning performing clinical trials in wide exhibit of topographies and advancement of medications in particular restorative zones are few components in charge of the developing interest for the CROs in pharmaceutical section. As indicated by BioOutsource, the interest for biosimilars testing is required to increment in the U.S. This is credited to the way that the FDA at long last began tending to the absence of clear direction with respect to biosimilars, particularly how the engineers ought to demonstrate that their medications are like that of the originator item. In January 2015, Hospital submitted one of the biosimilar renditions of Epogen (Epoetin Alfa) and the consequence of the survey in the U.S. is expected from the FDA inside a year.


The land dispersion of clinical trials is gradually moving from created countries to rising nations. The increasing expense of clinical trials and trouble in persistent enrolment has driven biopharmaceutical organizations to move towards locales, for example, focal and Eastern Europe, Asia Pacific, Latin America and Middle-East for cost proficiency and snappy patient recruitment. Emerging nations likewise have more prominent malady variety contrasted with west, where conventional infections are developing. The more prominent malady variety among the creating nations encourages biopharmaceutical organizations to perform clinical trials from uncommon sicknesses. Digitization in biomedical research is preparing for development of worldwide clinical trial showcase. Selection of Systems like EDC is additionally helping organizations to better deal with their patient information which eventually lessens the observing expense and help in better patient consistence. Digitization likewise helps in meeting the stringent directions by keeping up tolerant information records which at last aides in decreasing clinical trials process mistakes.

Scientific Sessions

Abstract Submission : Closed

Early Bird Registration : Closed

  • Clinical Trials on Different Diseases
  • Design of Clinical Studies and Trials
  • Site Management Innovation
  • Bioethics and Regulatory Compliance
  • Future of Clinical Trials
  • Epidemiology and Public Health
  • Innovations in Pre-clinical Research
  • Clinical Data Management and Statistics:
  • Patient Recruiting & Retention
  • Covid-19 clinical trials
  • Oncology Clinical Research
  • Biomarkers in Clinical Trials
  • Healthcare Outcomes and Pharmacoeconomics
  • HIV Clinical Trials
  • Paid Research Studies Market Analysis
  • Patient Stratification and Individualized Therapies
  • Randomized Controlled Trials
  • Latest technologies in Biomedical Research
  • Advancements in Psychology Research Methods
  • Stem Cell and Genetic Clinical Research

Registration Categories

Abstract Submission : Closed

Early Bird Registration : Closed


Participants desiring to be considered for one of these awards need to specify their interest after their submission of the required abstract. Selected participants will receive felicitation certificates under three categories:

  1. Outstanding Submitted Abstract
  2. Best Research of the conference as evaluated by the Scientific Committee
  3. Young Researcher Award under YRF category to encourage budding scientists/ researcher.

Decisions will be made based on evaluation of the submitted abstract by the Scientific Committee. The decision made by the Scienctific Committe would be final. We want you to grab this opportunity and participate in the conference...!